Population pharmacokinetic–pharmacodynamic modelling in oncology: a tool for predicting clinical response

por Bender, Brendan C, Schindler, Emilie, Friberg, Lena E
Publicado 2015

Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2‐negative breast cancer patients treated with docetaxel

por Krishnan, Sreenath M., Laarif, Sofiene S., Bender, Brendan C., Quartino, Angelica L., Friberg, Lena E.
Publicado 2021

P1078: MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATIENTS WITH RELAPSED AND/OR REFRACTORY FOLLICULAR LYMPHOMA WHO HAVE RECEIVED ≥2 PRIOR THERAPIES: UPDATED ANALYSIS OF A PIVO...

por Sehn, Laurie H., Bartlett, Nancy L., Matasar, Matthew, Schuster, Stephen J., Assouline, Sarit, Kuruvilla, John, Shadman, Mazyar, Cheah, Chan, Fay, Keith, Ku, Matthew, Nastoupil, Loretta J., Wei, Michael, Yin, Shen, To, Iris, Hu, Nan, Min, Juliana, Penuel, Elicia, Belousov, Anton, Coimbra, Alexandre, Jemaa, Skander, Bender, Brendan, Turner, David, Elizabeth Budde, L.
Publicado 2023